Skip to main content

LMR Partners LLP

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1578621 LONDON, X0

Position in TRVI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,193,000
-$59,000 QoQ
Shares Held
100,000
0.0% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Derivatives in TRVI

reported options exposure · as of Jun 30, 2025
CallValue
$0
CallShares
0
PutValue
$547
PutShares
100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

LMR Partners LLP holds $223,407,665 across 59 Biotechnology names. TRVI ranks #23 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,193,000 100,000
2025-12-31 $1,252,000 100,000
2025-09-30 $915,000 100,000
2025-06-30 $547,000 100,000
2025-06-30 $547 100
2025-03-31 $629,000 100,000